These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21501887)

  • 1. Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial.
    Kuhn A; Gensch K; Haust M; Schneider SW; Bonsmann G; Gaebelein-Wissing N; Lehmann P; Wons A; Reitmeir P; Ruland V; Luger TA; Ruzicka T
    J Am Acad Dermatol; 2011 Jul; 65(1):54-64, 64.e1-2. PubMed ID: 21501887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus.
    von Pelchrzim R; Schmook T; Friedrich M; Worm M
    Int J Dermatol; 2006 Jan; 45(1):84-5. PubMed ID: 16426386
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study.
    Madan V; August PJ; Chalmers RJ
    Clin Exp Dermatol; 2010 Jan; 35(1):27-30. PubMed ID: 19549244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study.
    Tzung TY; Liu YS; Chang HW
    Br J Dermatol; 2007 Jan; 156(1):191-2. PubMed ID: 17199600
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group.
    Ruzicka T; Bieber T; Schöpf E; Rubins A; Dobozy A; Bos JD; Jablonska S; Ahmed I; Thestrup-Pedersen K; Daniel F; Finzi A; Reitamo S
    N Engl J Med; 1997 Sep; 337(12):816-21. PubMed ID: 9295241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.
    Chen SL; Yan J; Wang FS
    J Dermatolog Treat; 2010 May; 21(3):144-56. PubMed ID: 20394490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment.
    Antille C; Saurat JH; Lübbe J
    Arch Dermatol; 2004 Apr; 140(4):457-60. PubMed ID: 15096374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
    Abramovits W; Fleischer AB; Jaracz E; Breneman D
    J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment.
    Doss N; Kamoun MR; Dubertret L; Cambazard F; Remitz A; Lahfa M; de Prost Y
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):321-9. PubMed ID: 19563466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
    Krejci-Manwaring J; McCarty MA; Camacho F; Manuel J; Hartle J; Fleischer A; Feldman SR
    J Drugs Dermatol; 2008 Jul; 7(7):643-6. PubMed ID: 18664156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
    Wollenberg A; Reitamo S; Girolomoni G; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
    Allergy; 2008 Jul; 63(7):742-50. PubMed ID: 18592619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: a randomized, double-blind trial.
    Meurer M; Eichenfield LF; Ho V; Potter PC; Werfel T; Hultsch T
    J Dermatolog Treat; 2010 May; 21(3):157-66. PubMed ID: 20394491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
    Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
    Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.